US CMO Advanced Bioscience Laboratories (ABL) has bought French immunogenicity services firm Platine Pharma citing additional global reach as the driver for the deal.
The acquisition – financial terms of which were not disclosed – will add Platine’s laboratory in Lyon which provides services for the biopharmaceuticals, food and cosmetics industries to ABLs network.
Specific capabilities include flow cytometry, ELISpot, ELISA, multiplex, Singulex and MSD capabilities. Platine also offers its Immuno’line T-cell activation service, a unique approach to assess the immune responses candidate drugs, immunotherapies and vaccine elicit.
ABL CEO Thomas VanCott said: “With laboratories based in France and the US, ABL is better positioned to support our clients’ increasingly global clinical development strategies.”